Clinical Trial Update: Ga-68 Dolacga PET Scan in HCC Under RFA

View source ↗

Summary

A National Taiwan University Hospital trial is evaluating Ga-68 Dolacga PET imaging for hepatocellular carcinoma under radiofrequency ablation; the study is not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Ga-68 Dolacga

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Hepatocellular Carcinoma (HCC), Radiofrequency Ablation | Status: NOT_YET_RECRUITING